Search

Elena I Afonina

from Half Moon Bay, CA
Age ~64
Get Report
Also known as:
Elena Ivanovna Afonina, Elena I Asonina, Elena Gulnik, Elena A
Related to:
Cynthia H Brinich-Langloi, 41Sergei Gulnik, 62Elena ATatiana Gulnik, 38Tanya GulnikSergei Gulnik
Connected to:
Nadia Afonin, 59Alfonso R Afonso, 72Alfredo Afonso, 55Antonia L Afonso, 85Helder N Afonso, 47Helena M Afonso, 57Jorge Afonso, 38Nicole M Afonso, 33Roberto Afonso, 48Vanessa Afonso, 42

Elena Afonina Phones & Addresses

  • Half Moon Bay, CA
  • 6528 Hirabayashi Dr, San Jose, CA 95120
  • Miami, FL
  • 8004 Meadowview Dr, Frederick, MD 21702

Resumes

Resumes

Elena Afonina Photo 1

Director Flow Cytometry Assays And Applications Development

View page
Location:
Hartford, CT
Industry:
Medical Devices
Work:
Beckman Coulter - Miami/Fort Lauderdale Area since Mar 2012
Senior Manager Clinical Applications Development
Beckman Coulter - Miami/Fort Lauderdale Area Dec 2009 - Mar 2012
Senior Staff Development Scientist
Sequoia Pharmaceuticals, Inc. - Gaithersburg, MD Jun 2002 - Oct 2009
Director Molecular and Cellular Biology
Tibotec - Rockville, MD 1999 - 2001
Sr scientist
National Cancer Institute 1991 - 1998
PostDoctoral Fellow
Education:
Lomonosov Moscow State University (MSU) 1978 - 1983
PhD, biochemistry, molecular biology
Skills:
Ivd Product Development
Multi Color Flow Cytometry
Strategic Planning
Clinical Diagnostics
Structure Based Drug Design
Cell Based Assay Development
Cellular Immunology
Molecular and Cellular Biology
Project Management
Design Control
510 K Submission
Ind Submission
Small Molecule Drug Developement
Assay Development
Hardware Diagnostics
Medical Devices
Biotechnology
Lifesciences
Capa
Immunoassays
Laboratory Automation
Immunology
Glp
Drug Design
Commercialization
Flow Cytometry
Medical Diagnostics
Fda
In Vitro Diagnostics
Cell Culture
Pharmaceutical Industry
Protein Chemistry
Hematology
Pharmacology
Cancer
Molecular Biology
Cell Biology
Laboratory
Clinical Development
Molecular Diagnostics
Drug Development
Biochemistry
Cell
Infectious Diseases
Biopharmaceuticals
Languages:
Russian
Elena Afonina Photo 2

Elena Afonina

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Elena Afonina
Director
Sequoia Pharmaceuticals, Inc
Commercial Physical Research · Druggists' Goods Merchant Whols
267 Kentlands Blvd, Gaithersburg, MD 20878
401 Professional Dr, Gaithersburg, MD 20879
(240) 632-0094, (240) 632-0465

Publications

Us Patents

Long Lasting Fusion Peptide Inhibitors For Hiv Infection

View page
US Patent:
20050065075, Mar 24, 2005
Filed:
May 31, 2002
Appl. No.:
10/478811
Inventors:
John Erickson - Frederick, CA
Dominique Bridon - Quebec, CA
Martin Robitaille - Quebec, CA
Grant Krafft - Glenview IL, US
Dong Xie - Germantown MD, US
Elena Afonina - Frederick MD, US
Jun Liang - Boyds MD, US
Sandra DeMeyer - Beerse, BE
International Classification:
A61K038/16
C07K014/47
US Classification:
514012000, 530324000
Abstract:
The present invention relates to C34 peptide derivatives that are inhibitors of viral infection and/or exhibit antifusogenic properties. In particular, this invention relates to C34 derivatives having inhibiting activity against human immunodeficiency virus (HIV), respiratory syncytial virus (RSV), human parainfluenza virus (HPV), measles virus (MeV), and simian immunodeficiency virus (SIV) with long duration of action for the treatment of the respective viral infections.

Long Acting Biologically Active Conjugates

View page
US Patent:
20070207952, Sep 6, 2007
Filed:
Mar 24, 2004
Appl. No.:
10/550715
Inventors:
Abelardo Silva - Ellicott City MD, US
John Erickson - Potomac MD, US
Michael Eissenstat - Frederick MD, US
Elena Afonina - Frederick MD, US
Sergei Gulnik - Frederick MD, US
Assignee:
SEQUOIA PHARMACEUTICALS - Gaithersburg MD
International Classification:
A61K 38/16
A61K 38/10
C07K 14/47
C07K 7/08
US Classification:
514012000, 530326000, 530324000, 530325000, 514013000, 424078270
Abstract:
The invention provides biologically active compounds that may be reacted with macromolecules, such as albumin, to form covalent linked complexes wherein the resulting complexes exhibit a desired biological activity in vivo. More specifically, the complexes are isolated complexes comprising a biologically active moiety covalently bound to a linking group and a protein. The complexes are prepared by conjugating a biologically active moiety, for example, a renin inhibitor or a viral fusion inhibitor peptide, with purified and isolated protein. The complexes have extended lifetimes in the bloodstream as compared to the unconjugated molecule, and exhibit biological activity for extended periods of time as compared to the unconjugated molecule. The invention also provides anti-viral compounds that are inhibitors of viral infection and/or exhibit anti-fusiogenic properties. In particular, this invention provides compounds having inhibiting activity against viruses such as human immunodeficiency virus (HIV), respiratory syncytial virus (RSV), human parainfluenza virus (HPV), measles virus (MeV), and simian immunodeficiency virus (SIV) and that have extended duration of action for the treatment of viral infections.

Long Lasting Fusion Peptide Inhibitors For Hiv Infection

View page
US Patent:
20110166061, Jul 7, 2011
Filed:
Apr 26, 2010
Appl. No.:
12/767646
Inventors:
John W. Erickson - Frederick MD, US
Dominique P. Bridon - Quebec, CA
Martin Robitaille - Quebec, CA
Grant A. Krafft - Glenview IL, US
Dong Xie - Germantown MD, US
Elena Afonina - Frederick MD, US
Jun Liang - Boyds MD, US
Sandra De Meyer - Beerse, BE
Assignee:
CONJUCHEM BIOTECHNOLOGIES, INC. - Montreal
International Classification:
A61K 38/16
C07K 14/00
A61P 31/18
US Classification:
514 38, 530324, 514 213
Abstract:
The present invention is concerned with This invention relates to C34 peptide derivatives that are inhibitors of viral infection and/or exhibit antifusogenic properties. In particular, this invention relates to C34 derivatives having inhibiting activity against human immunodeficiency virus (HIV), respiratory syncytial virus (RSV), human parainfluenza virus (HPV), measles virus (MeV), and simian immunodeficiency virus (SIV) with long duration of action for the treatment of the respective viral infections.
Control profile
Elena I Afonina from Half Moon Bay, CA, age ~64 Get Report